Article Text
Commentary
The IL-33/ST2 axis: yet another therapeutic target in inflammatory bowel disease?
Statistics from Altmetric.com
Footnotes
-
Contributors AS researched, designed and wrote the commentary.
-
Competing interests None.
-
Provenance and peer review Not commissioned; externally peer reviewed.